JUL 07, 2018 1:40 PM PDT

A New Target for an Effective Gonorrhea Treatment

WRITTEN BY: Carmen Leitch

Many pathogenic microbes are gaining resistance to antibiotics, and the bacterium that causes the sexually transmitted disease gonorrhea, Neisseria gonorrhoeae, is no different. The recent rise of drug-resistant gonorrhea has caused some alarm, and the pathogen has been labeled a superbug; it cannot be treated with any class of available antibiotics. Now, researchers at OSU/OHSU College of Pharmacy and collaborators have identified a protein that underlies the microbe’s virulence, which may help develop new ways to treat the disease.

Globally, there are an estimated 78 million new cases of gonorrhea every year. The disease can cause ectopic pregnancy, pelvic inflammatory disease, epididymitis, and infertility. The risk of blindness is increased in babies born to infected mothers, who may not know they have the disease.

Related: Untreatable Cases of Gonorrhea are on the Rise

"The infections very often are silent," explained Oregon State University researcher Aleksandra Sikora. "Up to 50 percent of infected women don't have symptoms, but those asymptomatic cases can still lead to some very severe consequences for the patient's reproductive health, miscarriage or premature delivery."

Sikora led a research team along with the lab of Ann Jerse at the Uniformed Services University of the Health Sciences in Bethesda, Maryland; they found a new kind of protein that aids in the transport of fats, a lipoprotein, which is utilized by N. gonorrhoeae to evade the defensive powers of our immune system.
 
Special enzymes in the body, lysozymes, can break up fatty molecules called lipids that compose cell walls. That process is used to disrupt the walls of bacteria, killing them. The cells that make up protective barriers of our body, like skin or tissues surrounding organs, are loaded with lysozymes that can help keep foreign material out.

For pathogens, that’s meant finding a way around those lysozymes. Many bacteria have developed an outer membrane, thwarting lysozymes. 

This work revealed a new protein that inhibits them. It is only the second time a protein that acts against lysozyme has been found in the Neisseria genus. The protein was named SliC, short for surface-exposed lysozyme inhibitor of c-type lysozyme. The researchers confirmed the role of the protein in bacterial growth by using a mouse model.

This new target has created new candidates for engineering a vaccine or drug. Interfering with this lysozyme inhibitor could make the bacterium vulnerable to drugs and may reign in its ability to cause infection.

"This is the first time an animal model has been used to demonstrate a lysozyme inhibitor's role in gonorrhea infection," Sikora noted. "Together, all of our experiments show how important the lysozyme inhibitor is. This is very exciting."

 

Sources: AAAS/Eurekalert! Via Oregon State University, PLOS Pathogens

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 17, 2020
Microbiology
MAR 17, 2020
A Toxin Produced by C.difficile Can Damage Intestinal Stem Cells
Intestinal stem cells help regenerate the lining of the intestine, and that lining or epithelium plays a number of criti ...
APR 02, 2020
Chemistry & Physics
APR 02, 2020
Improved management of nitrate pollution
Researchers have finally succeeded in improving the mechanisms available for the degradation of nitrate pollution. Scien ...
APR 29, 2020
Microbiology
APR 29, 2020
Bacteria Exposed to Antibiotics are 'Primed' to Gain More Resistance
Antibiotics are critical drugs that have saved millions of lives, but bacteria can also gain resistance to them, renderi ...
MAY 04, 2020
Genetics & Genomics
MAY 04, 2020
Molecular Tools Reveal More About the Impacts of the Slave Trade
Scientists still have a lot to learn about the numerous and varied consequences of the transatlantic slave trade, which ...
JUN 01, 2020
Genetics & Genomics
JUN 01, 2020
Vaping Increases Oral Disease Risk After Only a Few Months
E-cigarettes have emerged as a healthier alternative to smoking, but many studies have suggested that vaping still poses ...
JUN 06, 2020
Microbiology
JUN 06, 2020
Connecting Changes in Land Use to Emerging Diseases
It's estimated that an astonishing 75% of emerging pathogens that infect people are zoonotic - they originate in animals ...
Loading Comments...